Table 1.

The relationships between PD-L1 and HIF1α expression and clinicopathologic characteristics of 85 thyroid carcinoma patients

Variables	No.	PD-L1		p	HIF1α		p
Positive	Negative	Positive	Negative
Total	85	57	28		64	21
Age (years)				0.885			0.856
＜45	48	32	16		37	11
≥45	37	25	12		27	10
Sex				0.159			0.880
Male	32	18	14		26	6
Female	53	39	14		41	12
Tumor size (mm3)				0.010*			0.055
≥40	57	44	13		47	10
＜40	28	13	15		17	11
T Stage				0.030*			0.084
T1 and T2	49	38	11		33	16
T3	36	19	17		31	5
Lymphocytic thyroiditis				0.219			0.051
Yes	39	23	16		25	14
No	46	34	12		39	7
TNM				0.005**			0.002**
Ⅰ+Ⅱ	47	38	9		42	5
Ⅲ+Ⅳ	38	19	19		22	16
Metastasis				0.000***			0.000***
Yes	35	15	20		18	17
No	50	42	8		46	4
Psammoma body				0.914			0.268
Yes	12	5	7		7	5
No	73	52	21		57	16
Calcification in stoma				0.442			0.116
Yes	43	31	12		36	7
No	42	26	16		28	14
PD-L1							0.000***
Positive	67				59	8
Negative	18				5	13

Note: *p<0.05, **p<0.01, ***p<0.001.

Abbreviations: HIF-1α, hypoxia-inducible factor 1α; PD-L1, programmed cell death-1 protein ligand 1.